Skip to main content
Signal8

Liminatus Pharma, Inc. (LIMNW)

Liminatus Pharma, Inc., situated in La Palma, California, is an immuno-oncology firm actively engaged in clinical trials, dedicated to pioneering innovative treatments for various cancers.

Sector: Biological Products, (No Diagnostic Substances)

Industry: Biotechnology

Liminatus Pharma, Inc. Warrants logo

Liminatus Pharma, Inc. Warrants

NASDAQ:LIMNWSub-class of LIMNHealthcare
+13.96%$0.0400
Mkt Cap$54K
EV-
Float-
O/S1.34M
VOL251 sh
$ Vol$10
RVOL1.31×
Inst Own-
SI0.1%
Net Cash/Sh-
Dilution
Liminatus Pharma, Inc. Warrants logoNASDAQ:LIMNW$0.0400+13.96%
FormDescription
8-K
8-K
8-K
10-Q
8-K
5.07
8-K
8.01,9.01
8-K
13G
Beneficial Ownership Report
4
OWNERSHIP DOCUMENT
13D/A
Beneficial Ownership Report (Active, Amended)
DEF 14A
Definitive Proxy Statement
4
OWNERSHIP DOCUMENT
3
OWNERSHIP DOCUMENT
13G/A
Beneficial Ownership Report (Amended)
8-K
PRE 14A
Preliminary Proxy Statement
S-1
D
06b
8-K
1.01,3.02,3.03,8.01,9.01
424B3
8-K
8-K
10-Q
10-K
Annual Report
8-K
5.03,9.01

1-25 of 109

    Liminatus Pharma, Inc. (LIMNW) SEC Filings: 10-K, 10-Q, 8-K | Signal8